Literature DB >> 22952388

Improved early identification of arthritis: evaluating the efficacy of Early Arthritis Recognition Clinics.

Jessica A B van Nies1, Elisabeth Brouwer, Floris A van Gaalen, Cornelia F Allaart, Tom W J Huizinga, Marcel D Posthumus, Annette H M van der Helm-van Mil.   

Abstract

OBJECTIVE: Only 31% of Dutch rheumatoid arthritis (RA)-patients visit a rheumatologist within 12 weeks after symptom onset; this is mainly due to delay at the level of the general practitioner (GP). In order to reduce delay of GPs in identifying early arthritis, we initiated an Early Arthritis Recognition Clinic (EARC).
METHODS: EARCs were initiated at the Leiden and Groningen University Medical Centers. At this EARC, patients filled in a questionnaire about their symptoms, followed by a short visit with only a full joint examination by an experienced rheumatologist. If arthritis was present the patient got an appointment the same week at the regular outpatient clinic. The main outcome parameter was the GP-delay; the secondary outcome parameter was the total delay. In both centres, patients included in early arthritis clinics that had arrived via regular referrals served as control group.
RESULTS: Four hundred patients visited the Leiden EARC and 212 patients the Groningen EARC. Arthritis was detected in 42% and 49% respectively. The median GP-delay for these arthritis patients was 2.0 (0.4-7.3) and 2.0 (0.4-10.0) weeks and the median total delay 8.6 (3.6-22.3) and 10.6 (3.1-30.8) weeks respectively. At these two clinics 59% and 51% of all arthritis patients and 65% and 53% of the patients that were subsequently diagnosed with undifferentiated arthritis or RA were seen within 12 weeks after symptom onset. In the Leiden and Groningen control groups that arrived via regular referrals, only 32% and 38% were seen within 12 weeks time.
CONCLUSIONS: The EARC increased the early identification of arthritis and RA.

Entities:  

Keywords:  Early Rheumatoid Arthritis; Epidemiology; Outcomes research

Mesh:

Year:  2012        PMID: 22952388     DOI: 10.1136/annrheumdis-2012-202289

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status.

Authors:  Debbie M Boeters; Leonie E Burgers; René Em Toes; Annette van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2019-08-14       Impact factor: 19.103

Review 2.  Strategies to predict rheumatoid arthritis development in at-risk populations.

Authors:  Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2014-08-04       Impact factor: 7.580

3.  Reappraisal of the diagnostic and prognostic value of morning stiffness in arthralgia and early arthritis: results from the Groningen EARC, Leiden EARC, ESPOIR, Leiden EAC and REACH.

Authors:  Jessica A B van Nies; Celina Alves; Audrey L S Radix-Bloemen; Cécile Gaujoux-Viala; Tom W J Huizinga; Johanna M W Hazes; Elisabeth Brouwer; Bruno Fautrel; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2015-04-23       Impact factor: 5.156

Review 4.  Help-seeking trajectory in patients with rheumatoid arthritis.

Authors:  Ingris Pelaez; Claudia Infante; Rosana Quintana
Journal:  Clin Rheumatol       Date:  2015-07-23       Impact factor: 2.980

Review 5.  Rheumatoid arthritis in Latin America: the importance of an early diagnosis.

Authors:  Licia Maria Henrique da Mota; Claiton Viegas Brenol; Penelope Palominos; Geraldo da Rocha Castelar Pinheiro
Journal:  Clin Rheumatol       Date:  2015-07-25       Impact factor: 2.980

6.  Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions.

Authors:  Martin Feuchtenberger; Axel Philipp Nigg; Michael Rupert Kraus; Arne Schäfer
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-10-02

7.  ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation.

Authors:  Debbie M Boeters; Leonie E Burgers; Eric H Sasso; Tom W J Huizinga; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2019-05-14       Impact factor: 5.156

8.  Delays between the onset of symptoms and first rheumatology consultation in patients with rheumatoid arthritis in the UK: an observational study.

Authors:  Rebecca Jayne Stack; Peter Nightingale; Clare Jinks; Karen Shaw; Sandy Herron-Marx; Rob Horne; Chris Deighton; Patrick Kiely; Christian Mallen; Karim Raza
Journal:  BMJ Open       Date:  2019-03-04       Impact factor: 2.692

9.  Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care.

Authors:  L E Burgers; J A van der Pol; T W J Huizinga; C F Allaart; A H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2019-05-07       Impact factor: 5.156

10.  Development and validation of a clinical rule for recognition of early inflammatory arthritis.

Authors:  Robin M Ten Brinck; Bastiaan T van Dijk; Hanna W van Steenbergen; Saskia le Cessie; Mattijs E Numans; Samantha L Hider; Christian Mallen; Annette van der Helm-van Mil
Journal:  BMJ Open       Date:  2019-02-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.